Growth hormone-releasing hormone induced transactivation of epidermal growth factor receptor in human triple-negative breast cancer cells
Eva Vacas(Universidad de Alcalá), Ana M. Bajo(Universidad de Alcalá)
Cited by 7
Related Papers
Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells
|Molecular and Cellular Endocrinology|2008|56
Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer
|Peptides|2010|54
Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells
|Regulatory Peptides|2007|35
RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells
|Molecular and Cellular Endocrinology|2011|30